Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.02 | 23.73 |
| PEG Ratio (TTM) | 0.03 | 4.38 |
| P/S Ratio (TTM) | 1.59 | 2.18 |
| P/B Ratio (TTM) | 2.09 | 2.56 |
| P/FCF Ratio (TTM) | N/A | 14.86 |
| Price to 5YR AVG Earnings Ratio | -0.90 | 5.53 |
| Price to 5YR AVG FCF Ratio | -1.52 | 34.81 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.59% | 6.47% |
| ROE (TTM) | -20.31% | 3.84% |
| Net Profit Margin (TTM) | -17.65% | 6.90% |
| ROIC 5YR AVG | -21.37% | 9.24% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -897.65% | 32.04% | -0.78% |
| Revenue | 9.94% | -20.64% | -8.81% |
| Net Income | -903.39% | 33.48% | 257.10% |
| Cash Flow | -25.00% | -138.53% | 46.83% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.47 | 2.33 |
| Quick Ratio (TTM) | 1.46 | 2.23 |
| D/E Ratio (TTM) | 0.16 | 0.26 |
| Interest Coverage (TTM) | N/A | 132.40 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 4.20 |
| LTL to 5YR AVG FCF | -0.27 | 1.81 |
| Shares Outstanding Growth 5YR AVG | -19.83% | 31.03% |